What does Chromocell Therapeutics Corp. do?

Jun 22 2025 07:25 PM IST
share
Share Via
Chromocell Therapeutics Corp. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $7.52 million. Key financial metrics indicate it is not profitable, with a P/E ratio and dividend yield of 0.00%.
Overview:
Chromocell Therapeutics Corp. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.

Financial Snapshot:
Net Profit: -2 Million (Quarterly Results - Sep 2024)
Market Cap: USD 7.52 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.72
Return on Equity: -999,999.00%
Price to Book: -5.27

Contact Details:
Details: No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Chromocell Therapeutics Corp.?
Jun 22 2025 06:33 PM IST
share
Share Via